WALTHAM, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) — ‒ Histogenics and FDA Continue Discussions on NeoCart® Phase 3 Data and Potential BLA Submission ‒ ‒ October 2018 Financing Expected to Provide Funding Into Middle of 2019 ‒ ‒ Histogenics to Host Conference Call and Webcast Today at 8:30 a.m. ET ‒ Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a […]